Publications

Schold JD, Nordyke RJ, Wu Z, Corvino F, Wang W, Mohan S. 2022. Clinical events and renal function in the first year predict long-term kidney transplant survival. Kidney360 3(4):714-727; doi: 10.34067/KID.0007342021. PMID: 35721618.

Röth A, Fryzek J, Jiang X, Reichert H, Patel P, Su J, Morales Arias J, Broome CM. 2022. Complement-mediated hemolysis persists year round in patients with cold agglutinin disease. Transfusion 62(1):51-59; doi: 10.1111/trf.16745. PMID: 34813663.

Mavunda K, Jiang X, Ambrose CS. 2021. Prevalence and clinical characteristics of perinatal chronic lung disease by infant gestational age. J Neonatal Perinatal Med 14(1):43–51; doi: 10.3233/NPM-200412.

Mavunda K, Jiang X, Ambrose CS. 2021. Prevalence and clinical characteristics of perinatal chronic lung disease by infant gestational age. J Neonatal Perinatal Med 14(1):43–51; doi: 10.3233/NPM-200412.

Röth A, Fryzek J, Jiang X, Reichert H, Patel P, Su J, Morales Arias J, Broome CM. 2021. Complement-mediated hemolysis persists year round in patients with cold agglutinin disease. Transfusion 62(1):51-59; doi: 10.1111/trf.16745.

Feuerstadt P, Boules M, Stong L, Dahdal DN, Sacks NC, Lang K, Nelson WW. 2021. Clinical complications in patients with primary and recurrent Clostridioides difficile infection: A real-world data analysis. SAGE Open Med 9:2050312120986733; doi: 10.1177/2050312120986733. PMID: 33505698.

Hackshaw A, Cohen SS, Reichert H, Kansal AR, Chung KC, Ofman JJ. 2021. Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK. Brit J Cancer, open access.

Hackshaw A, Cohen SS, Reichert H, Kansal AR, Chung KC, Ofman JJ. 2021. Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK. Brit J Cancer 125(10):1432-1442; doi: 10.1038/s41416-021-01498-4. PMID: 34426664.

Snell Taylor SJ, Nielson CM, Breskin A, Saul B, Yu Y, Alam N, … Kelsh M, et al. 2021. Effectiveness and safety of romiplostim among patients with newly diagnosed, persistent and chronic immune thrombocytopenia in European clinical practice. Adv Ther 38(5):2673–2688.